Polymerase-δ-interacting protein 2 activates the RhoGEF epithelial cell transforming sequence 2 in vascular smooth muscle cells.

Autor: Huff LP; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Kikuchi DS; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Faidley E; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Forrester SJ; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Tsai MZ; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Lassègue B; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia., Griendling KK; Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, Georgia.
Jazyk: angličtina
Zdroj: American journal of physiology. Cell physiology [Am J Physiol Cell Physiol] 2019 May 01; Vol. 316 (5), pp. C621-C631. Date of Electronic Publication: 2019 Feb 06.
DOI: 10.1152/ajpcell.00208.2018
Abstrakt: Polymerase-δ-interacting protein 2 (Poldip2) controls a wide variety of cellular functions and vascular pathologies. To mediate these effects, Poldip2 interacts with numerous proteins and generates reactive oxygen species via the enzyme NADPH oxidase 4 (Nox4). We have previously shown that Poldip2 can activate the Rho family GTPase RhoA, another signaling node within the cell. In this study, we aimed to better understand how Poldip2 activates Rho family GTPases and the functions of the involved proteins in vascular smooth muscle cells (VSMCs). RhoA is activated by guanine nucleotide exchange factors. Using nucleotide-free RhoA (isolated from bacteria) to pulldown active RhoGEFs, we found that the RhoGEF epithelial cell transforming sequence 2 (Ect2) is activated by Poldip2. Ect2 is a critical RhoGEF for Poldip2-mediated RhoA activation, because siRNA against Ect2 prevented Poldip2-mediated RhoA activity (measured by rhotekin pulldowns). Surprisingly, we were unable to detect a direct interaction between Poldip2 and Ect2, as they did not coimmunoprecipitate. Nox4 is not required for Poldip2-driven Ect2 activation, as Poldip2 overexpression induced Ect2 activation in Nox4 knockout VSMCs similar to wild-type cells. However, antioxidant treatment blocked Poldip2-induced Ect2 activation. This indicates a novel reactive oxygen species-driven mechanism by which Poldip2 regulates Rho family GTPases. Finally, we examined the function of these proteins in VSMCs, using siRNA against Poldip2 or Ect2 and determined that Poldip2 and Ect2 are both essential for vascular smooth muscle cell cytokinesis and proliferation.
Databáze: MEDLINE